Iradimed (IRMD) Depreciation & Amortization (CF) (2013 - 2026)

Iradimed (IRMD) has reported Depreciation & Amortization (CF) for 14 consecutive years, with $410000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 97.12% year-over-year to $410000.0 in Q2 2026; TTM through Jun 2026 was $1.6 million, a 104.96% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 42.54% from the prior year.
• Depreciation & Amortization (CF) was $410000.0 for Q2 2026 at Iradimed, down from $455000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $494176.0 in Q2 2022 and troughed at -$692905.0 in Q4 2022.
• A 5-year average of $238047.4 and a median of $206687.5 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) slumped 279.23% in 2022 and jumped 134.54% in 2026, its largest moves.
• Over 5 years, Depreciation & Amortization (CF) stood at -$692905.0 in 2022, then jumped by 129.64% to $205375.0 in 2023, then declined by 4.95% to $195210.0 in 2024, then jumped by 95.01% to $380680.0 in 2025, then gained by 7.7% to $410000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $410000.0 (Q2 2026), $455000.0 (Q1 2026), and $380680.0 (Q4 2025), per Business Quant data.